LUCY Innovative Eyewear Inc
Ophthalmic Goods · Nasdaq · SEC CIK 1808377 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY56.9%
TTM net income YoY-3.7%
TTM EPS YoY42.4%
Revenue 3-yr CAGR83.9%
Net income 3-yr CAGR—
Margins
Gross margin22.7%
Operating margin—
Net margin-216.8%
FCF margin—
EBITDA margin—
Returns
ROE-92.4%
ROA-84.0%
ROIC (approx.)—
Asset turnover0.39x
Leverage & solvency
Liabilities / assets10.2%
Debt / equity0.00x
Current ratio9.12x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.89x
Accruals ratio-9.1%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.01M | $1.01M | $773,561 | $959,810 | $668,128 | $579,230 | $454,501 | $690,688 |
| Cost of revenue | $688,786 | $768,004 | $598,116 | $845,064 | $423,291 | $591,895 | $233,968 | $596,969 |
| Gross profit | $320,910 | $242,515 | $175,445 | $114,746 | $244,837 | -$12,665 | $220,533 | $93,719 |
| R&D expense | $423,353 | $142,093 | $138,109 | $116,604 | $129,984 | $268,224 | $210,576 | $214,915 |
| SG&A expense | $1.58M | $1.22M | $1.59M | $1.55M | $1.28M | $1.31M | $1.09M | $947,075 |
| Income tax | $0 | $0 | $0 | — | $0 | $0 | $0 | — |
| Net income | -$2.29M | -$1.67M | -$2.31M | -$1.87M | -$1.84M | -$2.11M | -$1.78M | -$2.13M |
| EPS (basic) | -0.27 | -0.26 | -0.37 | — | -0.38 | -0.66 | -0.72 | — |
| EPS (diluted) | -0.27 | -0.26 | -0.37 | — | -0.38 | -0.66 | -0.72 | — |
| Weighted avg. shares (diluted) | 8.42M | 6.41M | 6.25M | — | 4.87M | 3.21M | 2.45M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $3.20M | $2.46M | $4.38M | $6.51M | $6.70M | $7.63M | $5.26M | $2.63M |
| Receivables | $242,275 | $136,402 | $71,506 | $142,152 | $83,358 | $57,957 | $89,664 | $107,918 |
| Inventory | $1.68M | $1.77M | $1.40M | $1.75M | $1.63M | $1.68M | $1.13M | $831,757 |
| Current assets | $7.56M | $6.79M | $8.75M | $9.44M | $10.60M | $11.33M | $7.33M | $9.24M |
| PP&E, net | $26,585 | $31,368 | $50,224 | $61,777 | $58,243 | $58,330 | $127,008 | $107,562 |
| Intangibles | $593,998 | $627,930 | $599,609 | $559,968 | $421,491 | $435,043 | $457,750 | $451,302 |
| Total assets | $8.21M | $7.47M | $9.48M | $10.14M | $11.18M | $11.94M | $7.94M | $9.84M |
| Current liabilities | $829,291 | $562,726 | $1.09M | $1.05M | $884,651 | $606,060 | $447,241 | $737,718 |
| Total liabilities | $836,314 | $574,385 | $1.11M | $1.07M | $925,003 | $658,518 | $447,241 | $743,168 |
| Shareholders' equity | $7.37M | $6.90M | $8.37M | $9.07M | $10.25M | $11.28M | $7.49M | $9.10M |
| Shares outstanding | 8.71M | 6.41M | 6.30M | 5.48M | 5.21M | 4.57M | 2.45M | 2.45M |
| Cash flow statement | ||||||||
| Operating cash flow | -$1.55M | -$1.86M | -$2.49M | -$1.35M | -$1.50M | -$2.12M | -$2.31M | -$1.94M |
| Capital expenditure | — | — | — | $17,030 | $14,835 | $0 | $40,648 | $26,455 |
| Free cash flow | — | — | — | -$1.37M | -$1.51M | -$2.12M | -$2.35M | -$1.97M |
| Investing cash flow | -$283,370 | -$26,510 | -$1.05M | $824,870 | -$14,835 | -$1.27M | $4.94M | -$61,421 |
| Financing cash flow | $2.57M | -$32,433 | $1.40M | $336,965 | $584,402 | — | — | $89,851 |
| Depreciation & amortization | $4,783 | $8,431 | $11,553 | $13,496 | $14,922 | $17,168 | $21,202 | $25,582 |
| Stock-based compensation | $198,325 | $198,325 | $200,992 | $206,153 | $169,304 | $164,714 | $177,576 | $264,254 |
Free plan shows the latest 8 periods; Pro shows all 23 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.